# Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

> **NCT04674332** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 148 (actual)

## Conditions studied

- Long Acting Insulin in Control of Gestational Diabetes Mellitus

## Interventions

- **DRUG:** Long acting insulin
- **DRUG:** multiple dose regimen

## Key facts

- **NCT ID:** NCT04674332
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2020-12-14
- **Final completion:** 2020-12-14
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2021-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674332, "Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04674332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*